Bin Ye

Dr. Bin Ye


Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
XWXiaojing Wang
Xiaojing Wang
LWLiangjing Wang
Liangjing Wang
LGLin Geng
Lin Geng
Naoki TanakaNaoki Tanaka
Naoki Tanaka
BYBin Ye
Bin Ye
Resmetirom, a liver-directed, orally active agonist of THR-β, could play a favorable role in treating NASH, but little is known about the underlying mechanism. A NASH cell model was established to test the preventive effect of resmetirom on this disease in vitro. RNA-seq was used for screening, and rescue experiments were performed to validate the target gene of the drug. A NASH mouse model was used to further elucidate the role and the underlying mechanism of resmetirom. Resmetirom effectively eliminated lipid accumulation and decreased triglyceride (TG) levels. In addition, repressed RGS5 in the NASH model could be recovered by resmetirom treatment. The silencing of RGS5 effectively impaired the role of resmetirom. In the NASH mouse model, obvious gray hepatization, liver fibrosis and inflammation, and increased macrophage infiltration were observed in liver tissues, while resmetirom almost returned them to normal conditions as observed in the control group. Pathological experimental data also confirmed that resmetirom has great potential in NASH treatment. Finally, RGS5 expression was suppressed in the NASH mouse model, but it was upregulated by resmetirom treatment, while the STAT3 and NF-κB signaling pathways were activated in NASH but inhibited by the agent. Resmetirom could improve NASH by recovering RGS5 expression and subsequently inactivating the STAT3 and NF-κB signaling pathways.

29 April 2006 in Neural Computing and Applications
Verified
Journal Article
Closed access
PDF file
BYBin Ye
Bin Ye
CZC. Z. Zhu
C. Z. Zhu
YCY. J. Cao
Y. J. Cao

19 August 2026 in Biology Direct
Verified
Journal Article
Open access
PDF file
MDMugen Dai
Mugen Dai
JWJianbo Wang
Jianbo Wang
QXQing Xu
Qing Xu
YSYixiu Shao
Yixiu Shao
HWHan Wang
Han Wang
BYBin Ye
Bin Ye
Gastric cancer (GC) is one of the most lethal malignancies worldwide, and hepatic metastasis is a major cause of its poor clinical prognosis. The stemness